Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.94% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Target
TGT
$69.9B
| $172M | 0.05% |
1,302,896
+28,011
| +2% | +$4.16M |
|
352
Boston Scientific
BSX
$74.5B
| $171M | 0.04% |
3,167,582
+596,549
| +23% | +$31.2M |
|
353
First Trust Enhanced Short Maturity ETF
FTSM
$6.54B
| $171M | 0.04% |
2,882,240
-35,241
| -1% | -$2.1M |
|
354
Sherwin-Williams
SHW
$87.4B
| $171M | 0.04% |
644,708
+38,115
| +6% | +$8.97M |
|
355
Cencora
COR
$60B
| $170M | 0.04% |
884,648
+186,162
| +27% | +$32.2M |
|
356
Hershey
HSY
$37B
| $169M | 0.04% |
675,912
-70,744
| -9% | -$18.6M |
|
357
Berkshire Hathaway Class A
BRK.A
$1.09T
| $166M | 0.04% |
321
-1
| -0.3% | -$498K |
|
358
iShares Biotechnology ETF
IBB
$9.86B
| $165M | 0.04% |
1,298,932
-523,930
| -29% | -$68.1M |
|
359
O'Reilly Automotive
ORLY
$74.5B
| $164M | 0.04% |
2,580,810
-142,650
| -5% | -$8.71M |
|
360
iShares Russell Mid-Cap ETF
IWR
$57.9B
| $163M | 0.04% |
2,226,209
+52,579
| +2% | +$3.66M |
|
361
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $163M | 0.04% |
1,562,408
+5,567
| +0.4% | +$579K |
|
362
Fortinet
FTNT
$118B
| $160M | 0.04% |
2,118,244
+708,821
| +50% | +$48.2M |
|
363
AstraZeneca
AZN
$246B
| $160M | 0.04% |
1,118,175
-28,913
| -3% | -$4.25M |
|
364
Cadence Design Systems
CDNS
$89B
| $160M | 0.04% |
680,410
-300,904
| -31% | -$65.5M |
|
365
Sempra
SRE
$56.2B
| $158M | 0.04% |
2,173,484
+100,004
| +5% | +$7.51M |
|
|
366
PUT
NVIDIA
NVDA
$5.43T
| $157M | 0.04% |
3,718,000
+2,712,000
| +270% | +$90M |
|
367
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
| $155M | 0.04% |
3,710,899
-645,385
| -15% | -$26.7M |
|
|
ERF
368
DELISTED
Enerplus Corporation
ERF
| $155M | 0.04% |
10,695,456
+1,109,181
| +12% | +$16.2M |
|
369
UBS Group
UBS
$177B
| $153M | 0.04% |
7,553,670
-1,743,984
| -19% | -$35.1M |
|
370
Principal Financial Group
PFG
$24.4B
| $152M | 0.04% |
2,002,886
-161,755
| -7% | -$11.7M |
|
371
Sonoco
SON
$5.74B
| $151M | 0.04% |
2,566,627
+32,230
| +1% | +$1.94M |
|
|
BBU
372
DELISTED
Brookfield Business Partners
BBU
| $149M | 0.04% |
8,650,879
+114,754
| +1% | +$2.1M |
|
373
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $148M | 0.04% |
1,991,025
+43,323
| +2% | +$3.17M |
|
374
Ametek
AME
$59.3B
| $147M | 0.04% |
910,734
+16,443
| +2% | +$2.4M |
|
375
Cigna
CI
$73.3B
| $147M | 0.04% |
524,937
+153,600
| +41% | +$40M |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.